Skip to content
Directory

Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
18
currently held
Exits tracked
6
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity

Capital Event · capital-cancellation-shares · Capital structure change

capital

Capital Event · capital-cancellation-shares · Capital structure change

capital

Capital Event · capital-cancellation-shares · Capital structure change

capital
Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Board change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board

admin
Ardian1 month ago

Chairman update · Chairman update: du conseil de surveillance Thomas, Patrick · Chairman information updated

admin
21 companies matching
HTBA
HTBA
Miura Fund III
Spain
Active
Sector
Pharma
InvestorMiura Partners
Entry
2019
Hold
6yr
Owners
2
Nuzoa
Nuzoa
PAI Mid-Market Fund
Spain
Active
Sector
Pharma
InvestorPAI Partners
Entry
2020
Hold
5yr
Owners
2
Natac Group
Natac Group
Stellum Food & Tech I
Spain
Active
Sector
Pharma
InvestorStellum Capital
Entry
2021
Hold
3yr
Owners
2
Diater
Diater
Fondo Nazca Small Cap I
Spain
Exited
Sector
Pharma
InvestorNazca Capital
Entry
2019
Hold
4yr
Exit
2023
to WORG Pharma
Curapath
Curapath
Columbus Innvierte Life Science Fund I
Spain
Exited
Sector
Pharma
InvestorColumbus Venture Partners
Entry
2017
Hold
4yr
Exit
2021
to Arcline Investment Management
Idifarma
Sodena Direct
Spain
Exited
Sector
Pharma
InvestorSodena
Entry
2006
Hold
15yr
Exit
2021
to Ardena
Ojer Pharma
Ojer Pharma
Easo Ventures II
Spain
Active
Sector
Pharma
InvestorEaso Ventures
Entry
2014
Hold
12yr
Owners
2
3P Biopharmaceuticals
3P Biopharmaceuticals
Eurazeo Private Debt V
Spain
Active
Sector
Pharma
InvestorEurazeo
Entry
2019
Hold
7yr
Advanthera
Advanthera
Columbus Life Sciences Fund IV
Spain
Active
Sector
Pharma
InvestorColumbus Venture Partners
Entry
2024
Hold
2yr
Cuantum Medical Cosmetics
Cuantum Medical Cosmetics
Inveready Biotech II
Spain
Active
Sector
Pharma
InvestorInveready Asset Management
Entry
2015
Hold
11yr
Farmalider
Farmalider
MCH Iberian Capital Fund V
Spain
Active
Sector
Pharma
InvestorMCH Private Equity Investments
Entry
2023
Hold
3yr
IRAB
IRAB
MED Rise
Spain
Active
Sector
Pharma
InvestorARCHIMED
Entry
2026
Hold
0yr
Linneo Health
Linneo Health
Torreal
Spain
Active
Sector
Pharma
InvestorTorreal
Entry
2018
Hold
8yr
Medical Plants
Medical Plants
Realza Capital Fund II
Spain
Active
Sector
Pharma
InvestorRealza Capital
Entry
2021
Hold
5yr
Noucor
Noucor
MCH Iberian Capital Fund V
Spain
Active
Sector
Pharma
InvestorMCH Private Equity Investments
Entry
2022
Hold
4yr
Rioja Nature Pharma
Rioja Nature Pharma
Tresmares Private Equity Fund II
Spain
Active
Sector
Pharma
InvestorTresmares Capital
Entry
2023
Hold
3yr
Unolab Manufacturing
Unolab Manufacturing
ProA Capital Iberian Buyout Fund II
Spain
Active
Sector
Pharma
InvestorProA Capital
Entry
2016
Hold
10yr
Alcala Farma
Latin American Private Equity Fund VII
Spain
Active
Sector
Pharma
InvestorAdvent International
Entry
–
Laboratorios Ovejero
ADE Capital Sodical
Spain
Active
Sector
Pharma
InvestorSodical
Entry
2018
Hold
8yr
Montplet
Corpfin Capital Fund VI
Spain
Active
Sector
Pharma
InvestorCorpfin Capital
Entry
2025
Hold
1yr
Vivunt Pharma
ADE Capital Sodical
Spain
Active
Sector
Pharma
InvestorSodical
Entry
2022
Hold
4yr